Esperion Therapeutics | Beneficio Operativo



Operating Profit Cambio Fecha
AbbVie USD 3.73B 5.22B 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amarin USD -16755000 35.77M 2025-03
Amgen USD 1.29B 1.02B 2025-03
Biogen USD 311.2M 130.2M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Cipla INR 12.29B 4.8B 2025-03
CSL USD 1.98B 778M 2024-12
Cytokinetics USD -155631000 16.59M 2025-03
Daiichi Sankyo JPY 83.61B 22.2B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Geron USD -16704000 5.05M 2025-03
Grifols EUR 371.86M 54.83M 2024-12
Halozyme Therapeutics USD 141.54M 33.97M 2025-03
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
Merck USD 5.87B 1.57B 2025-03
Moderna USD -1050000000 196M 2025-03
Pfizer USD 3.67B 4.08B 2025-03
PTC Therapeutics USD 970.22M 1.03B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Sanofi EUR 2.28B 1.42B 2025-03
Sarepta Therapeutics USD -300386000 462.07M 2025-03
United Therapeutics USD 382.8M 25.1M 2025-03



Esperion Therapeutics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.